Dow Up0.35% Nasdaq Down0.02%

More On REPCF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


RepliCel Life Sciences Inc. (REPCF)

-Other OTC
0.48 0.00(0.00%) 8:10PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 3,878   -   -  
Cost of Revenue -   -   -  
Gross Profit 3,878   -   -  
Operating Expenses
Research Development1,470  1,070  1,001  
Selling General and Administrative2,047  3,424  2,665  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 361   (4,493) (3,666)
Income from Continuing Operations
Total Other Income/Expenses Net0  1,116  20  
Earnings Before Interest And Taxes361  (3,378)(3,647)
Interest Expense -   -   -  
Income Before Tax361  (3,378)(3,647)
Income Tax Expense388   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(27)(3,378)(3,647)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (27) (3,378) (3,647)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (27) (3,378) (3,647)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.